| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/16/2010 | EP2196201A2 Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms |
| 06/16/2010 | EP2196195A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 06/16/2010 | EP2195030A1 Isoflavone formulation |
| 06/16/2010 | EP2195029A2 Treatment and prevention of neurodegenerative diseases |
| 06/16/2010 | EP2194976A1 Hepatitis c antiviral compositions and methods |
| 06/16/2010 | EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/16/2010 | EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine |
| 06/16/2010 | EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/16/2010 | EP1349857B1 Purine derivatives as purinergic receptor antagonists |
| 06/16/2010 | CN1997361B Antitumor agent |
| 06/16/2010 | CN1921865B Use of meloxicam for the treatment of respiratory diseases in pigs |
| 06/16/2010 | CN1771040B Remedy for diabetes. |
| 06/16/2010 | CN1635864B Oligosaccharide aldonic acids and their topical use |
| 06/16/2010 | CN101743020A low-viscous anthracycline formulation |
| 06/16/2010 | CN101743001A Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 06/16/2010 | CN101732728A Anti-inflammatory drug (polysaccharide conjugate) as well as preparation and application of drug composition thereof |
| 06/16/2010 | CN101732724A Composite micelle carrying anti-tumor medicine and preparation method thereof |
| 06/16/2010 | CN101732718A Pharmaceutical composition containing NCX inhibitors |
| 06/16/2010 | CN101732717A Ttk in diagnosis and as a therapeutic target in cancer |
| 06/16/2010 | CN101732712A NOGO-A resisting antibody and vessel conglutinin inhibitor for treating cerebral apoplexy |
| 06/16/2010 | CN101732563A Application of composite from trametes robinioplila murr, wolfberry and sealwort |
| 06/16/2010 | CN101732328A Medicinal composition and injection for treating swine eperythrozoonosis, and preparation methods thereof |
| 06/16/2010 | CN101732298A Treating benign prostate hyperplasia with sarms |
| 06/16/2010 | CN101229375B Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 06/16/2010 | CN101045161B Modulators of P-selectin glycoprotein ligand 1 |
| 06/15/2010 | US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 06/15/2010 | US7737264 Oligomeric compounds for the modulation HIF-1α expression |
| 06/15/2010 | US7737179 Methods for treatment of dermatological conditions |
| 06/15/2010 | US7737162 Viral inhibitors |
| 06/15/2010 | US7737147 Administering l-deprenyl or propargylamine compounds; treating male and female sexual disorders, brain disorders, vascular disorders, anorectal disorders, stroke or inflammatory disorders, and depression |
| 06/15/2010 | US7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 06/15/2010 | US7737118 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time |
| 06/15/2010 | US7736675 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and/or a chitosan derivative and an antioxidant such as vitamin C and vitamin E |
| 06/15/2010 | US7736674 Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 06/15/2010 | US7736649 preventing the viral entry process into target cells, by inhibiting the binding of viral surface glycoprotein to cell surface CD4, to fusion coreceptors CCR5 chemokine receptors and the transient conformation fusion intermediate that ultimately folds into a conformation capable of mediating fusion |
| 06/15/2010 | US7736639 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders |
| 06/15/2010 | US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 06/15/2010 | CA2521647C Novel hydroxamates as therapeutic agents |
| 06/15/2010 | CA2463668C Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 06/15/2010 | CA2410253C Regulating lipid levels via the zmax1 or hbm gene |
| 06/15/2010 | CA2407072C Taste masking coating composition |
| 06/15/2010 | CA2404696C Medicament containing tissue inhibitor of metalloproteinases-2 (timp-2) as an osteoanabolically active substance |
| 06/15/2010 | CA2303820C Metal compounds, mixed or sulphated, as phosphate binders |
| 06/10/2010 | WO2010065936A1 High penetration compositions and their applications |
| 06/10/2010 | WO2010064736A1 Therapeutic agent for cancer |
| 06/10/2010 | WO2010064441A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof |
| 06/10/2010 | WO2010064422A1 Method for killing tumor by photosensitization treatment under conditions where histone is highly acetylated |
| 06/10/2010 | WO2010064254A1 Novel multi purpose composition |
| 06/10/2010 | WO2010063488A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 06/10/2010 | WO2010063486A1 Use of eltoprazine for the treatment of l-dopa-induced dyskinesia |
| 06/10/2010 | WO2010045601A3 Synergistic combination of sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
| 06/10/2010 | WO2010045415A3 Topical nsaid compositions having sensate component |
| 06/10/2010 | WO2010031832A3 Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative |
| 06/10/2010 | WO2010029131A9 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs |
| 06/10/2010 | WO2010028845A3 Use of an ang-(1-7) receptor agonist in acute lung injury |
| 06/10/2010 | WO2009147170A3 Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| 06/10/2010 | US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction) |
| 06/10/2010 | US20100145180 Apparatus for physical measurements of the eye |
| 06/10/2010 | US20100145071 Small molecule inhibitors of rotamase enzyme activity |
| 06/10/2010 | US20100144837 Diagnosis and treatment of malignant neoplasms |
| 06/10/2010 | US20100144665 Treatment of statin side effects |
| 06/10/2010 | US20100144661 Sodium channel blockers |
| 06/10/2010 | US20100144660 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer thereapy |
| 06/10/2010 | US20100143962 Nanoparticulate polycosanol formulations & novel polycosanol combinations |
| 06/10/2010 | US20100143473 Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions |
| 06/10/2010 | US20100143440 Ul97 inhibitors for treatment of proliferative disorders |
| 06/10/2010 | US20100143435 Scaffold with increased pore size |
| 06/10/2010 | US20100143417 Compositions and methods for controlling diseases in animals |
| 06/10/2010 | US20100143415 Streptococcus Pneumoniae Antigens |
| 06/10/2010 | US20100143339 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 06/10/2010 | US20100143310 SPINAL NERVE REPAIR PROMOTING THERAPEUTICS CONTAINING GHRELIN OR ITS DERIVATIVES OR SUBSTANCES THAT ACT ON GHS-R1a AS AN ACTIVE INGREDIENT |
| 06/10/2010 | US20100143308 Akt nucleic acids, polypeptides, and uses thereof |
| 06/10/2010 | US20100143306 Use of bone marrow cells for long term culture of pancreatic islet cells |
| 06/10/2010 | US20100143302 Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof |
| 06/10/2010 | US20100143297 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density |
| 06/10/2010 | DE102008060904A1 Wasserlösliche Wirkstoffe in Sprühpflaster Water-soluble active ingredients in spray-on |
| 06/10/2010 | DE102008059206A1 Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum A pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic |
| 06/10/2010 | CA2745206A1 High penetration compositions and their applications |
| 06/10/2010 | CA2744960A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 06/09/2010 | EP2194067A2 Antibodies to insulin-like growth factor I receptor (IGF-IR) |
| 06/09/2010 | EP2193808A1 Synergistic combination |
| 06/09/2010 | EP2193807A1 Cyclosporin a-binding protein |
| 06/09/2010 | EP2193806A1 Agent for promoting corneal endothelial cell adhesion |
| 06/09/2010 | EP2193805A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 06/09/2010 | EP2193794A1 Use of eltoprazine for the treatment of L-Dopa-induced dyskinesia |
| 06/09/2010 | EP2193791A1 The treatment of respiratory diseases |
| 06/09/2010 | EP2193790A1 IL-3 Inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 06/09/2010 | EP2193204A2 Novel lipophilic compositions and uses thereof |
| 06/09/2010 | EP2192919A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |
| 06/09/2010 | EP1459727B1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound |
| 06/09/2010 | EP1385864B1 Anti-VEGF-2 antibodies |
| 06/09/2010 | EP1011686B1 Modulation of human mast cell activation |
| 06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
| 06/09/2010 | CN1871000B Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
| 06/09/2010 | CN1780610B Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 06/09/2010 | CN1679957B A pharmaceutical composition containing liposomes for treating a cancer |
| 06/09/2010 | CN1646115B Use of SARMS in preparing medicine for treating benign prostate hyperplasia |
| 06/09/2010 | CN101730547A Drug combination and its use in the treatment of muscle loss |
| 06/09/2010 | CN101730546A Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 06/09/2010 | CN101721710A Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method |